Literature DB >> 35290494

[CyPass microstent trimming with special cutting forceps : Video article].

Cosima Rose1, Marc Schargus2.   

Abstract

OBJECTIVE OF SURGERY: A CyPass®-microstent (Alcon, Fort Worth, TX, USA) extending too far into the anterior chamber should be trimmed as close as possible to the scleral spur to avoid progression of endothelial cell reduction. INDICATIONS: After CyPass implantation, if there is a significant loss of corneal endothelial cells due to the Cypass microstent extending too far into the anterior chamber, trimming or removal of the CyPass stent is necessary. CONTRAINDICATIONS: There are no contraindications. SURGICAL TECHNIQUE: As shown in our video, which is available online, a special cutter (19 Gauge Ahmed Micro Stent Cutter, MicroSurgical Technology Inc, Redmond, WA, USA) is inserted into the anterior chamber via a 1.5-mm wide corneal paracentesis made directly opposite to the CyPass stent. It is then possible to trim the anterior part of the stent. The severed fragment is removed using the head of the forceps. Finally, the previously inserted viscoelastic agent can be aspirated and the paracentesis can be hydrated. POSTOPERATIVE TREATMENT: After the surgery vision testing as well as control of intraocular pressure and location of the stent are carried out. Antibiotic eye drops and ointment are postoperatively applied. EVIDENCE: There is still no standardized protocol for the procedure to trim the CyPass stent. Performing the trimming in our clinic using the procedure described here has so far not led to any complications. Long-term data about the development of the endothelial cell measurement after CyPass trimming are not yet available.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Corneal endothelium; Endothelial cell loss; Microinvasive glaucoma surgery; Primary open-angle glaucoma; Surgery

Mesh:

Year:  2022        PMID: 35290494     DOI: 10.1007/s00347-022-01596-5

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  3 in total

1.  Safety and Effectiveness of CyPass Supraciliary Micro-Stent in Primary Open-Angle Glaucoma: 5-Year Results from the COMPASS XT Study.

Authors:  George Reiss; Bill Clifford; Steven Vold; Jonathan He; Cody Hamilton; Jaime Dickerson; Stephen Lane
Journal:  Am J Ophthalmol       Date:  2019-08-01       Impact factor: 5.258

Review 2.  [Microsurgical trimming of the CyPass stent : Surgical procedure of the Neubrandenburg Eye Clinic. Video article].

Authors:  Ahmed Medra; Mathias Schwanengel; Annegret Weber; Christian Karl Brinkmann
Journal:  Ophthalmologe       Date:  2020-12       Impact factor: 1.059

Review 3.  Suprachoroidal devices in glaucoma surgery.

Authors:  Jeffrey A Kammer; Kevin M Mundy
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Jan-Mar
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.